Chagas disease, caused by the obligate unicellular parasite Trypanosoma cruzi, presents itself in a diverse collection of clinical manifestations, ranging from severe, fatal heart and digestive tract pathologies to unapparent or minor alterations that do not compromise survival. Over the years, a number of mechanisms have been proposed to explain the pathogenesis of chagasic tissue lesions, all of which have faced some criticism or been received with skepticism. This article excludes the autoimmunity hypothesis for Chagas disease because it has been extensively reviewed elsewhere, and summarizes the various alternative hypotheses that have been advanced over the years. For each of these hypotheses, an outline of its main tenets and key findings that support them is presented. This is followed by the results and comments that have challenged them and the caveats that stand on their way to wider acceptance. It is hoped that this writing will draw attention to our shortcomings in understanding the pathogenesis of Chagas disease, which, unfortunately, continues to figure among the most serious health problems of the American continent.
Introduction
Soon, it will be nearly one century since Carlos Chagas reported a new pathological entity (now known as Chagas disease or American trypanosomiasis) and its etiologic agent, the obligate intracellular parasite Trypanosoma cruzi (Chagas 1909 ). Yet, our knowledge of the mechanisms underlying the pathogenesis of this disease remains limited, fragmented, and for the most part mired in controversy. In the last three decades, the much disputed notion that autoimmune events may be the root cause of the pathology associated with Chagas disease has drawn attention away from other proposed, equally plausible mechanisms. Many recent articles have discussed the findings that support or undermine the autoimmunity hypothesis (Kierszenbaum 1986 (Kierszenbaum , 1999 (Kierszenbaum , 2003 (Kierszenbaum , 2005 Eisen and Kahn 1991; Avila 1992; Fernandez et al. 1992; Kalil and CunhaNeto 1996; Brener and Gazzinelli 1997; Andrade 1999; Soares et al. 2001; Engman 2001, 2002; Gironés and Fresno 2003; Gironés et al. 2005) . To avoid unnecessary repetition, this article will focus on hypotheses other than autoimmunity, hoping to stimulate renewed interest in all aspects of the pathogenesis of Chagas disease and broaden the scope of the discourse on this subject.
By most expert accounts, Chagas disease is not a single pathological entity. Nor is it a uniform disease presenting in the same form or even with a similar pattern in all patients. Thus, not every patient infected with T. cruzi experiences the abnormalities characteristic of the three phases of Chagas disease: acute, indeterminate, and chronic. Moreover, pathological developments and symptoms vary widely among chagasic patients , Brener and Andrade 1979 , Storino and Milei 1986 , Andrade et al. 1994 , Elizari 1999 , Rassi et al. 2000 . Illustrating this diversity and the complexity of Chagas disease is the fact that only one third (approximately) of individuals infected with T. cruzi progress to the chronic phase. It is in this phase that the disease takes its heaviest toll, most frequently in the form of cardiomyopathy, megaesophagus or megacolon , Storino and Milei 1986 , Kiss et al. 1986 , Andrade et al. 1994 , Elizari 1999 , Rassi et al. 2000 .
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In most patients, the early period of T. cruzi infection goes virtually unnoticed whereas others develop an acute phase that lasts several weeks and is accompanied by non-specific symptoms such as, for example, fever, tachycardia, weakness, and lymphadenopathy Andrade 1979, Storino and Milei 1986) . Localized skin inflammation at the parasite's portal of entry (referred to as a chagoma) may be seen in some patients (Rassi 1979 ) and some present RomaZa's sign (RomaZa 1963 , Rassi 1979 . The latter is a distinctive unilateral palpebral and periorbital edema that develops when T. cruzi, deposited on the skin of the face with the fecal fluids from an infected insect vector, access the conjunctiva and causes regional lymphadenopathy. During the acute phase, T. cruzi is often microscopically detectable in the bloodstream. Death resulting from acute Chagas disease is not very frequent, rarely exceeding 5% of the cases, and results from myocarditis, meningoencephalitis, or respiratory complications (Andradrade and Andrade 1979, Storino and Milei 1986) . Myocarditis can be detected in some, but not all acute cases of Chagas disease (Parada et al. 1997 , Fuenmayor et al. 2005 .
Most chagasic patients survive the acute stage and enter the indeterminate phase, defined by the absence of symptoms (although subclinical pathology may be present). Indeterminate Chagas disease may last years and even decades with cardiomyopathy going undetected in electrocardiograms and chest X-rays (Macedo 1999) . However, an estimated two thirds of indeterminate patients have subclinical myocardial lesions (Davila et al. 1989) .
Chronic Chagas disease manifests itself mostly in the form of severe heart pathology leading to arrhythmias, ventricular apical aneurism, and congestive heart failure (Amorim et al. 1979 , Storino and Milei 1986 , Higuchi 1995 , Rossi et al. 1996 , Rassi et al. 2000 , Elizari 2002 , Rocha et al. 2003 , Kirchhoff et al. 2004 . In some geographic areas (e.g., central parts of Brazil), the number of patients presenting megaesophagus or megacolon has occasionally reached endemic proportions (Andrade and , de Rezende 1979 .
The course and pathology of Chagas disease are thought to depend on host genetic, environmental, and even cultural factors, as well as the genotypic class of T. cruzi, which has been postulated to determine infectivity and virulence (Oliveira et al. 1997 , Buscaglia and Di Noia 2003 , Campbell et al. 2004 . It is also possible that T. cruzi infectivity and other biological characteristics may be modulated during its interactions with reduviid insect vectors (Coronado et al. 2006) .
Trypanosoma cruzi infects a variety of mammalian host tissues and cells, but heart, esophagus, or intestinal pathologies are the most common and severe forms of chronic chagasic disease, often with fatal consequences. A key question awaiting a definitive answer is: What mechanism(s) is involved in producing these devastating effects? Linked to this question, and certainly not less important, is another one asking: What determines who will develop the most serious characteristics of chronic Chagas disease and how? Described below are the most salient hypotheses addressing -at least partially -these questions. Currently, none of these mechanisms overrides or rules out any of the others and some of them may conceivably co-exist.
Inflammation, a hallmark of Chagas disease
In mammalian hosts, T. cruzi replication occurs in the cytoplasm of different types of cells, including macrophages, fibroblasts, skeletal and heart muscle cells, and endothelial cells , Storino and Milei 1986 , Andrade 1999 . Trypomastigotes released from infected cells can infect neighboring cells or disseminate to other organs through blood and lymphatic vessels (Pinto Dias 1979 , Bijovsky et al. 1984 . Invasion and destruction of host cells represents the earliest documented manifestation of tissue damage associated with T. cruzi infection. Inflammation is indeed a key characteristic of the pathology of Chagas disease. There is ample evidence that the most severe forms of the disease are defined by damage to vital tissues generally framed by inflammation (Andrade and Andrade 1979, Storino and Milei 1986) , strongly suggesting that T. cruzi and damaged tissue can constitute suitable stimuli for the recruitment of inflammatory cells. Our current understanding is that inflammatory-type cells can contribute to host defense (by eliminating parasites) as well as compound tissue damage Kierszenbaum 1984a, b, 1986; Kierszenbaum et al. 1986; Storino and Milei 1986; Molina and Kierszenbaum 1987 , 1988a , b, 1989a Villalta et al. 1987) . The extent of inflammation in vital organs such as the heart varies during the course of Chagas disease, tending to be mild and transient in most acute patients, and occasionally detected in patients traversing the indeterminate phase. In the chronic phase, however, inflammation commingles with various degrees of tissue necrosis and fibrosis. Mononuclear cell infiltration (macrophages and substantial numbers of T cells) is typical in chagasic heart tissue lesions, progressing from multifocal to diffuse. Although the parasite is seldom seen microscopically at chronic tissue lesions, the use of more sensitive detection methods such as polymerase chain reaction or histochemistry, has routinely identified parasite-derived material in them (reviewed by Kierszenbaum 1999 Kierszenbaum , 2003 .
Activated neutrophils and eosinophils are rather aggressive inflammatory-type cells known to destroy T. cruzi and mammalian cells (Kierszenbaum et al. 1981 Kierszenbaum 1984a, b, 1986; Kierszenbaum 1987, 1988a, b; Villalta et al. 1987; Molina et al. 1988 Molina et al. , 1989a . Although these cells are not as abundant as mononuclear cells at chronic chagasic lesions, their numbers in myocardial tissue have been found to correlate with the severity of heart tissue lesions, reaching their highest levels at sites where necrosis and cell degeneration is identified Kierszenbaum 1987, 1988a) . At these particular sites, degranulation by activated neutrophils and eosinophils is readily demonstrable by immunohistochemical methods (Molina and Kierszenbaum 1989a) . In vitro studies have shown that normal human neutrophils or eosinophils incubated with T. cruzi 2 OEl¹ski can cause damage to bystander mammalian cells (Molina and Kierszenbaum 1989b) . No such damage was seen in control cultures lacking either the inflammatory cells or the parasite, indicating that their interaction resulted in the production of molecules displaying toxicity on bystander cells. Reagents that specifically inhibit or neutralize human neutrophil or eosinophil granule components prevented bystander mammalian cell destruction in this system, thus pointing to eosinophil and neutrophil granule components as the actual lytic agents.
At inflammatory foci, activated T cells produce cytokines such as, for example, interferon-γ and tumor necrosis factor-α (Klessig and Chow 1980; Nabors and Tarleton 1991; Torrico et al. 1991; Silva et al. 1992 Silva et al. , 1995 Zhang and Tarleton 1996; Cunha-Neto et al. 1998; Talvani et al. 2000 Talvani et al. , 2004 D'AngeloMendoza et al. 2005) . These cytokines may directly or indirectly affect the physiology of cardiac tissue and contribute to chagasic pathology (see "The oxidative stress hypothesis", below), while other types of inflammatory-type cells, notably neutrophils, eosinophils, and macrophages may, upon regulation by some of these cytokines, affect tissue integrity.
Involvement of chemokines and chemokine receptors in the development of chagasic heart inflammatory lesions
Chemokines are powerful biological chemoattractants capable of recruiting mobile cells to their various tissue destinations. Expression of CXCL9 (a chemokine previously known as MIG, for monokine induced by interferon-γ), CXCL10 (IP-10, interferon-γ-inducible protein of 10 kDa), CCL3 (MIP-1α, macrophage inflammatory protein-1α), CCL4 (MIP-1β, macrophage inflammatory protein-1β, and CCL5 (RANTES, regulated on activation normal T cell expressed and secreted) is demonstrable in heart tissues of T. cruzi-infected mice (Machado et al. 2005; Hardison et al. 2006a, b) . Studies on the role of some chemokines in the recruitment of T cells and macrophages, cells that are prominently present at murine and human chagasic inflammation foci, have been facilitated by the availability of CCR5 -/-mice, whose cells cannot respond to CCL3, CCL4, and CCL5, specific ligands for CCR5. Compared to wild-type (CCR5 +/+ ) mice, the levels of parasitism in blood and cardiac tissue of acutely infected CCR5 -/-were much higher, with consequent increases in the mortality rate. These results were in keeping with those published by Machado et al. (2005) . Smaller numbers of inflammatory cells were present in the atria and ventricles of CCR5 -/-mice acutely infected with T. cruzi, suggesting deficient or delayed recruitment of mononuclear cells (i.e., CD4 and CD8 T cells, and macrophages). Diminished T cell and macrophage activation did not appear to be the reason for reduced migration of inflammatory cells to the heart in the CCR5 -/-mice, since the capacities of T cells and macrophages to produce cytokines and nitric oxide, respectively, were comparable in CCR5 -/-and CCR5 +/+ mice. Without additional information, mere recruitment of inflammatory cells cannot be assumed to point to a role of the chemokines mentioned above in the pathogenesis of myocarditis. It should also borne in mind that T cells and macrophages are active in host defense against T. cruzi infection in mice (Kierszenbaum et al. 1974; de Araujo-Jorge 1989; Russo and Starobinas 1991; Tarleton 1991 Tarleton , 1995 Kuhn 1994) .
The altered migration of T cells and macrophages to heart tissue of CCR5 -/-mice was not sustained in the chronic phase, becoming comparable with that of the wild-type controls (Hardison et al. 2006b ). Treatment of infected mice with anti-CCL5 antibody did not ameliorate heart inflammation (Hardison et al. 2006a, b) . The reason for the spontaneous reversal is not understood. Any extrapolation of these findings to human Chagas disease would be premature and unwarranted, given that the transition from acute to chronic Chagas disease in most susceptible mouse strains occurs in a matter of few weeks, as opposed to the many years that it takes human patients to come out of the indeterminate phase and present overt cardiomyopathy.
Whereas inflammation is a major component of the pathology of Chagas disease, the text below indicates that a number of scientists believe that other mechanisms of tissue damage may play significant roles as well.
The neurogenic hypothesis
The neurogenic hypothesis for pathogenesis in chagasic tissue lesions was initially advanced by Köberle (1958 Köberle ( , 1961 Köberle ( , 1974 . It is largely based on (a) observations of damage to ganglionic tissue associated with affected chagasic cardiac tissue and (b) reduced numbers of neurons in the myenteric plexus, which lies between the inner and outer muscular layers of the gastrointestinal tract and provides motor innervation to it. This hypothesis contends that a loss of neurons affects tissues of the heart, esophagus and intestine. According to it, destruction of vagal neurons by T. cruzi curtails or abrogates the counterbalancing effects of sympathetic responses, leading to uncompensated predominance of the latter and a consequent hypersensitivity to catecholamines. These events would start in the early stages of Chagas disease, continue throughout the course of the disease, and eventually lead to the serious heart or gastrointestinal tissue alterations seen in chronic chagasic patients. Doubts have followed the neurogenic hypothesis ever since its inception. Thus, in some of Köberle's early articles reduced numbers of vagal neurons were also apparent in unaffected regions of chagasic heart tissue (Köberle 1974) .
Also, some investigators have been cautious regarding the neurogenic hypothesis because studies carried out in mice infected with different strains of the T. cruzi could not establish intraganglionic parasitism as being a readily reproducible finding. Moreover, inflammation of peripheral nervous tissue was not only of a focal nature but also unpredictable (de Souza et al. 1996) . It has been pointed out that the number of neurons in different areas of ganglia and in different ganglia varies considerably, particularly in intestinal ganglia (de Souza et al. 1996) . This has raised the possibility that apparent decreases in neuron counts may have been representative of a variability of neuron content rather than T. cruzi infection. More pre-cise and standardized measurements would be needed before drawing firm conclusions about the neurogenic hypothesis.
Cases of chagasic megaesophagus and megacolon tend to be confined to a few geographic locations within the much larger endemic territory of Chagas disease (Andrade and Andrade 1979, Guevara et al. 1997 , World Health Organization 2002 . So far, it has been difficult to explain why T. cruzi, a pathogen with an extended geographic coverage, would be restricted from causing a certain type of pathology in certain locations. Similar considerations apply to chagasic cardiomyopathy, which represents approximately one third of T. cruziinfected individuals in just about any population or geographic area that has been studied , Storino and Milei 1986 , Storino et al. 2002 , de Oliveira-Marques et al. 2005 , Pompilio et al. 2005 . In this context, it is noteworthy that, in recent times, a fair amount of attention has been devoted to linking biological features of T. cruzi, including infectivity and virulence, with their genotypes (McDaniel and Dvorak 1993 , Buscaglia and Di Noia 2003 , Campbell et al. 2004 . A consensus is emerging that the genetic diversity of T. cruzi clones present in the heterogeneous populations carried and transmitted by insect vectors is an important factor in the multi-faceted aspects of Chagas disease (Andrade and Magalhaes 1996 , Vago et al. 2000 , Devera et al. 2003 , Tibayrenc 2003 , Williams-Blangero et al. 2003 , Campbell et al. 2004 , Macedo et al. 2004 , Coronado et al. 2006 ).
Davila and his colleagues have observed that alterations of the cardiac parasympathetic nervous system, with continuous activation of the sympathetic nervous system, occur late in the natural history of Chagas disease rather than in the earlier acute and indeterminate phases (Davila et al. 1998 (Davila et al. , 2002 Odreman et al. 2004) . Similar conclusions have been drawn by investigators studying neurohormonal imbalances resulting from deficient parasympathetic control in Chagas disease (Oliveira 1985 , Bestetti et al. 1995 , Ribeiro et al. 2002 . Of particular interest in this regard has been the report by Davila et al. (1998) that sympathetic and parasympathetic abnormalities are actually preceded by myocardial damage and left ventricular dysfunction. These observations imply that abnormalities of the autonomic nervous system of chagasic patients may be secondary to, and not the primary cause of heart tissue damage. This group of investigators also reported that neurohormonal activation representing insufficiently controlled sympathetic activity is transient in the acute phase of Chagas disease, most likely absent in the indeterminate phase, but permanent in the chronic phase (Davila et al. 1998 . This view seems to be consistent with the earlier results of Oliveira (1985) , showing that marked losses of parasympathetic denervation occur in chagasic patients with severe myocarditis, i.e., in their chronic phase.
It would take incontrovertible evidence of significant ganglionic neuronal losses in the acute and indeterminate phases of Chagas disease for the neurogenic hypothesis to be widely accepted, at least as originally proposed. However, other studies have shown cardiac autonomic function to be essentially normal in patients with indeterminate Chagas disease but abnormal in patients presenting overt cardiac disease (Caeiro et al. 1980 , Junqueira et al. 1985 , Junqueira and Soares 2002 . These observations appear to oppose the tenets of the neurogenic hypothesis, since parasympathetic alterations do not seem to be a significant factor in Chagas disease prior to the onset of the chronic phase (Davila et al. 1989 (Davila et al. , 1998 .
Chagasic patients with megaesophagus or megacolon seldom present evidence of concomitant heart disease or a loss of parasympathetic function at the heart level (Andrade and Andrade 1979, Olsen 1982, Storino and Milei 1986) . Conversely, overt Chagas heart disease is seldom accompanied by megaesophagus or megacolon (Andrade and Andrade 1979, Storino and Milei 1986) . This raises the question: Why would T. cruzi infection selectively affect vagal neurons at only some tissue locations in the same patient?
Some investigators (Davila et al. 1989 ) have brought up the possibility that cardiac parasympathetic alterations may be a consequence, rather than the cause, of chagasic heart disease. They observed that the parasympathetic heart rate control was normal when myocardial damage was limited and not accompanied by significant ventricular enlargement, and also noted the existence of a correlation between the degree of alteration of the parasympathetic heart rate control and the extent of ventricular dilatation. Therefore, vagal neuron destruction might be an indicator of ongoing diffuse heart disease and not necessarily a causative mechanism of chagasic pathogenesis. Consistent with this view is the observation that both, decreased numbers of heart vagal neurons and cardiac parasympathetic dysfunction occur in non-chagasic heart conditions, including dilated (congestive) cardiomyopathy (Amorim and Olsen 1982).
The oxidative stress hypothesis
In murine T. cruzi infection, inflammatory reactions have been shown to be accompanied by enhanced production of inflammatory-type cytokines which can, in turn, induce greater than normal production of nitric oxide and reactive oxygen species (ROS) (Machado et al. 2000 , Silva et al. 2003 , Zacks et al. 2005 . For example, interferon-γ, a cytokine that contributes to host defense against T. cruzi infection in mice (Reed 1988; Silva et al. 1992 Silva et al. , 2003 , possibly through its abilities to upregulate nitric oxide production and the destruction of T. cruzi by macrophages (Silva et al. 2003 , Zacks et al. 2005 . However, when increased levels of nitric oxide and ROS are not met by an adequate capacity to scavenge these toxic molecules, there is the potential for alteration of cardiac myocyte mitochondria, which could contribute to causing heart tissue damage (Silva et al. 2003 , Zacks et al. 2005 . Such are the tenets of the oxidative stress hypothesis.
It has been reported that complex I and complex III, components of the mitochondrial electron transport chain (ETC), exhibit repressed biochemical activities indicative of oxidative stress in myocardial tissue isolated from mice acutely infected with T. cruzi ). These two molec-ular complexes not only contribute to the formation and maintenance of the mitochondrial proton gradient (whose energy powers the mitochondrial ATP synthase that converts ADP and Pi into ATP) but also produce large amounts of ROS (as by-products of the respiratory chain) when they function suboptimally (Ide et al. 1999 , Wallace 2000 , Chen et al. 2003 . The activity of manganese-dependent superoxide dismutase, an enzyme that scavenges oxygen radical molecules, is reduced in myocardial tissue from chagasic mice (Wen et al. 2004) . Such decrease would be expected to lead to increased ROS levels and predispose heart tissue towards pathological events. Oxidative stress conditions have been documented in several non-chagasic heart diseases as well (Sawyer et al. 2002) .
The oxidative stress hypothesis opens a new and interesting avenue of research on the pathogenesis of Chagas and other heart diseases. However, it has not been established yet whether mitochondrial dysfunction is a causative factor in chagasic cardiomyopathy or just a mere indicator of pathology. Furthermore, because there are notable differences in both the susceptibility, pathology, and rates of progression of Chagas disease in human and murine hosts , it would be important to establish whether the alterations of the mitochondrial ETC seen in T. cruzi-infected mice occur also in the myocardium of chagasic patients. In this regard, it is noteworthy that reductions in succinate dehydrogenase activity, relevant to the mitochondrial Krebs cycle, have been observed in histochemical studies performed with endomyocardial biopsies from chagasic patients (Carrasco Guerra et al. 1987) . In this case, it is not clear to what extent decreased succinate dehydrogenase (i.e., the mitochondrial complex II) activity represents a deficiency in the functionality of the ETC, which would presumably remain competent if complexes I and III remained unaffected.
Overproduction of ROS unrelated to T. cruzi infection and its involvement in oxidative stress, with consequences to the integrity and survival of myocytes, has been described (Dhalla et al. 2000 , Sawyer et al. 2002 . It is too soon to conclude that chagasic cardiomyopathy results, even in part, from T. cruziinduced increases in the production of ROS. In fact, at this point in time, it would seem that cardiac damage common to chagasic and non-chagasic cardiomyopathies play a role in modifying mitochondrial activities, and not the other way around. In any case, a better understanding of oxidative stress in relation to cardiac tissue damage would be useful in the evaluation of its true role in the pathogenesis of Chagas disease and other heart diseases.
Endothelin-1 (ET-1) and vasculopathy in murine Chagas disease
Increased levels of ET-1 were found in the plasma of mice infected with a sublethal dose of T. cruzi (Petkova et al. 2001 , Tanowitz et al. 2005 . Elevated expression of mRNA for preproET-1 (the precursor of ET-1) and ET-1 itself, and increased amounts of endothelin-converting enzyme (which converts preproET-1 into ET-1) were found in myocardial tissue taken from these animals during the acute phase of the infection. These results suggested a role for ET-1 in pathogenesis because this molecule, which is produced by fibroblasts and cardiomyocytes, has been linked to vascular damage and cardiac remodeling (Kedziersky and Yanagisawa 2001) . Cardiac remodeling is generally defined in terms of changes in the size, shape and function of the heart caused by cardiac load or injury and is a major factor in the clinical course towards heart failure (Cohn et al. 2000) .
A milder form of Chagas disease ensued in T. cruzi-infected mice that had the ET-1-encoding gene deleted from their cardiomyocytes (Jelicks et al. 2003 , Tanowitz et al. 2005 . Moreover, inhibition of the endothelin-converting enzyme resulted in lesser degrees of pathology and reduced cardiac remodeling relative to controls. Beneficial effects of enzyme inhibition were evidenced by monitoring histopathology, echocardiography, and cardiac magnetic resonance imaging. Moreover, when isolated rat aortic rings were incubated with supernatants from T. cruzi-infected human umbilical vein endothelial cell cultures the recorded steady-state magnitude of the ring contractions was significantly greater than those produced by supernatants from uninfected control cells (Tanowitz et al. 1999) . All of these observations are consistent with a possible role for ET-1 in inducing vasoconstriction and having a possible modulatory role in the vascular alterations that occur in Chagas heart disease. The significance of these experimental findings to human chagasic cardiomyopathy remains to be established.
Natriuretic peptides and chagasic cardiomyopathy
Atrial and brain natriuretic peptides have been shown to be present at elevated concentrations in the circulation of acute chagasic patients and chronic chagasic patients with overt cardiomyopathy (Piazza et al. 1994 , Ribeiro et al. 2002 . In the latter group, atrial natriuretic peptides were readily detectable at the sites of subendocardial lesions in ventricular wall tissues, but not at inflammation sites away from these lesions. This particular distribution has suggested that natriuretic peptides are probably more of an indicator of established cardiac alterations than a factor in their genesis, possibly elicited by ventricular wall stress and, therefore, not unique to Chagas heart disease or specific for T. cruzi infection (Ribeiro et al. 2002) . This inference is in keeping with the recent observation that brain natriuretic peptide, a cardiac neurohormone, is produced by cardiomyocytes and cells infiltrating the heart tissue of non-chagasic patients with severe heart failure (Bruggink et al. 2006) . However, increased plasma concentrations of brain-type natriuretic peptide [produced by the ventricles of the heart in response to volume expansion and pressure overload (Maeda et al. 1998)] have been found in a number of non-chagasic cardiovascular diseases, including mildly reduced left ventricular diastolic function (Furumoto et al. 2006) , pressure-load cardiomyopathy (Vanderheyden et al. 2004) , and others (Cardarelli and Lumicao 2003, Witthaut 2004) . 
The microvascular disturbance hypothesis
The possibility that alterations in the coronary microcirculation leading to ischemia may be responsible for the type of heart tissue damage seen in chronic Chagas disease has been examined by several groups of investigators using experimental approaches (Rossi et al. 1984 , Factor et al. 1985 , Rossi 1990 , Mengel and Rossi 1992 , Marin-Neto et al. 1995 , Tanowitz et al. 1996 , Rossi 1997 , Ramos and Rossi 1999 . Among the first reports attracting attention to microvascular alterations in chagasic mammals was one describing a light and electron microscopy study of laboratory dog hearts removed 18 to 26 days after infection with T. cruzi, i.e., during the acute phase (Andrade et al. 1994) . Myocarditis with platelet aggregates and fibrin thrombi was demonstrable in intramyocardial capillaries, suggesting a link between microangiopathy and the myocardial tissue damage seen in this model system of Chagas disease. There have also been in vitro studies showing a number of alterations taking place in endothelial cells infected with T. cruzi, which might impact mechanisms relevant to microvascular perfusion and maintenance of tissue integrity (Morris et al. 1988 (Morris et al. , 1989 (Morris et al. , 1990 (Morris et al. , 1992 . Among the noted effects were changes in the production of molecules playing important roles in intracellular signaling such as [Ca 2+ ] i (Morris et al. 1988) , inositol trisphosphate (Morris et al. 1989) , prostaglandin I 2 (Morris et al. 1990) , and cyclic AMP (Morris et al. 1992) .
As for studies with chronic chagasic patients, there have been descriptions of structural derangement and altered vasculature seen in the left ventricular wall of hearts and also a post-mortem radiological study of chagasic hearts showing scarce vessels and decreased arterial density in the apex (Rossi et al. 1996) . Apical aneurism is a common occurrence in chronic Chagas heart disease (Brener and Andrade 1979 , Castagnino et al. 1982 , Storino and Milei 1986 . Capillary damage has also been observed in skeletal muscle of patients with advanced Chagas disease .
Ischemia, which according to the microvascular disturbance hypothesis is a major cause of chagasic myocardial tissue damage, is seen in only 10% of chagasic patients with chronic heart disease Marin-Neto et al. 1992 and is easier to spot in patients with chest pain (Marin-Neto et al. 1992) . This low frequency of occurrence suggests not only that myocardial ischemia may be uniquely related to this particular symptom in Chagas disease but also unlikely to be a general mechanism of pathogenesis in chagasic cardiomyopathy.
Myocardial hypoperfusion owing to an affected microvasculature has been noted in chagasic heart regions with normal or mildly impaired wall motion (Marin-Neto et al. 1995, Ramos and but myocardial capillary alterations and hypoperfusion are not exclusive to chagasic cardiopathy (Factor et al. 1983 (Factor et al. , 1985 Marin-Neto et al. 1995; Gavin et al. 1998) . Therefore, myocardial damage might precede microvascular disturbances. In any case, the precise mechanisms responsible for microvascular damage remain obscure and deserve further study.
Apoptosis of myocardial cells
There have been reports that molecules released by T. cruzi can induce apoptosis in mouse cells as varied as those from the spleen, thymus, and lymph nodes (Leguizamon et al. 1999) . In addition, signs of apoptosis have been detected in myocardial tissue from dogs infected with T. cruzi (Zhang et al. 1999) and also in T cells and thymus nursing cells from T. cruzi-infected mice (DosReis et al. 1995 , Barcinski and DosReis 1999 , DosReis and Barcinski 2001 , Mucci et al. 2002 , De Souza et al. 2003 . Studies performed with heart tissue from chronic chagasic patients have been conflictive in their identification of apoptotic myocardial cells at inflammatory sites Souza 1999, Tostes et al. 2005) . Moreover, there has been disagreement regarding the occurrence of apoptosis in experimental T. cruzi infection Souza 1999, Lopes and DosReis 2000) . It is noteworthy that the results of in vitro studies have indicated that not all T. cruzi biodemes induce apoptosis (De Souza et al. 2003) , suggesting that cardiac tissue damage via apoptosis may depend on which T. cruzi biodeme(s) infects a host. Readers interested in the relationships between T. cruzi genotypes and their pathological potential are referred to the excellent review by Campbell et al. (2004) . At the present time, the precise mechanisms that lead to apoptosis in T. cruzi-infected mammalian hosts (if or when it occurs) and the particular pattern of fibrosis commonly seen in chagasic myocarditis, characterized by the enveloping of myofibers by a dense extracellular collagen mesh , remain to be worked out.
Conclusions/Outlook
The literature on Chagas disease includes a large number of articles in which a certain metabolic activity, cell concentration or appearance, molecular concentration, or physiologic change is described and loosely proposed to play a role in pathogenesis. Discussion of these types of preliminary findings has been left for another occasion, as it would take a significant amount of space herein without adding much substance.
To-date, the only mechanism of host cell damage that appears to be beyond doubt or criticism is the bursting of host cells infected by T. cruzi. This event results in the release of intracellularly replicated trypanosomes, which then disseminate in the host or are taken up by insect vectors. When the destroyed cells are those of vital organs and fibrosis is extended, the pathological consequences can be readily visualized and understood. In contrast, indirect mechanisms involving several steps have always been more difficult to validate. Kinetic studies aimed at establishing clear links between those steps would be more persuasive and essential, buy are clearly considerably more difficult -if not outright impossible -to undertake in humans than in animals. While helpful and suggesting new research possibilities and approaches, experiments with laboratory animals have often faced skepticism from those who disagree with the premise that animals reproduce well all aspects of human Chagas disease.
The differences between the various hypotheses summarized in this article reflect the diversity of pathological features of Chagas disease. The biodeme heterogeneity of T. cruzi populations carried by insect vectors is well documented (Carrasco et al. 1996 , Devera et al. 2003 and may well be behind some of the controversies surrounding some of the proposed mechanisms of pathogenicity. Biodeme heterogeneity may also be a major factor hindering the reproducibility of findings made by groups working with different T. cruzi isolates or patients from distant geographic regions. Tissue tropism, infectivity, and virulence may ultimately be determined to a significant extent by what particular T. cruzi clone(s) is present in the parasite pools transmitted by insect vectors (Perlowagora-Szumlewicz et al. 1990 , Campbell et al. 2004 . T. cruzi heterogeneity might possibly result from multiple feedings by insect vectors on different infected individuals. Evidence has been mounting that genetic exchange in T. cruzi has occurred in nature (Souto et al. 1996 , Barnabe et al. 2001 , and has been shown to be practicable in the research laboratory (Bogliolo et al. 1996 , Stothard et al. 1999 , Gaunt et al. 2003 , Campbell et al. 2004 .
There is very little doubt that, under evolutionary pressure, T. cruzi has 'learned' much more about cell biology, physiology, immunology, pathology, and other biological sciences than students of Chagas disease have so far. We must hope and persevere, and continue to work to bring closer the day when enough is known and done to eradicate this scourge affecting large populations in vast areas of the American continent.
